1,590 research outputs found
Rapid switching between transdermal fentanyl and methadone in cancer patients
Purpose
The aim of this study was to examine the clinical effects of switching from transdermal (TTS)fentanyl to methadone, or vice versa, in patients with a poor response to the previous opioid.
Patients and Methods
A prospective study was carried out on 31 patients who switched from TTS fentanyl to oral
methadone, or vice versa, because of poor opioid response. A fixed conversion ratio of
fentanyl to methadone of 1:20 was started and assisted by rescue doses of opioids, and then
doses were changed according to clinical response. Pain and symptom intensity, expressed
as distress score, were recorded before switching doses of the two opioids and after
subsequent doses. The number of changes of the daily doses, time to achieve stabilization,
and hospital stay were also recorded.
Results
Eighteen patients were switched from TTS fentanyl to methadone, and seven patients were
switched from methadone to TTS fentanyl. A significant decrease in pain and symptom
intensity, expressed as symptom distress score, was found within 24 hours after switching
took place in both directions. Unsuccessful switching occurred in six patients, who were
subsequently treated with an alternative therapy.
Conclusion
A rapid switching using an initial fixed ratio of fentanyl to methadone of 1:20 is an effective
method to improve the balance between analgesia and adverse effects in cancer patients
with poor response to the previous opioid. No relationship between the final opioid dose and
the dose of the previous opioid has been found
Opioid-induced or pain relief-reduced symptoms in advanced cancer patients?
Background: While opioids in increasing doses may produce adverse effects, the same adverse effects may be associated with poor pain control. Moreover, in the clinical setting symptomatic treatment and illness may balance the outcome of opioid titration. Some adverse effects may tend to disappear continuing the treatment in a long-term period.
Aims: The aim of this study was to monitor the effects of a rapid opioid titration combined with symptomatic treatment in patients
with poor relief and to monitor these changes in the following period of 20 days.
Methods: A consecutive sample of 35 patients admitted to an acute Pain Relief and Palliative Care Unit were titrated with opioids,
according to a department policy, allowing administration of parenteral opioids to assist opioid titration with oral or transdermal
opioids.
Results: Thirty-three patients were followed up for the period of the study. Pain was adequately controlled and doses were opioid doses were stable after a mean of 40 h. Opioid escalation index (OEI) was extremely high initially, and then progressively declined at the following study intervals. Weakness and nausea and vomiting did not change, as well as confusion and appetite. Drowsiness, constipation and dry mouth significantly increased and then did not change, although a significant decrease in drowsiness was subsequently observed. Well-being improved some weeks after opioid stabilization. In multivariate analysis, drowsiness and dry mouth were correlated to opioid doses.
Conclusion: The effects reported were often due to multiple causes. A rapid decrease in pain intensity induced by rapid opioid titration
does not produce changes in weakness, nausea and vomiting, appetite. While constipation appears the most relevant problem,resistant to common symptomatic treatment, drowsiness initially produced by acute opioid dose increase and the achievement of pain relief, tends to spontaneously decrease, probably as the result of late tolerance. Improved well-being may be the late positive effect of pain relief, also influenced by the setting of home care
Prevalence and molecular characterization of Aereomonas spp. in ready-to-eat foods in Italy
A survey was carried out in Italy to ascertain the prevalence of Aeromonas spp. in ready-to-eat foods (vegetables, cheeses, meat products, and ice creams) and the level of molecular heterogeneity of the isolates found by macrorestriction analysis of genomic DNA with pulsed-field gel electrophoresis (PFGE). In total, 46 (14.4%) of the 320 food samples examined were found positive for Aeromonas spp. The highest percentages of isolation were discovered in vegetables, particularly lettuce (45.0%), endive (40.0%), and rucola (20.0%). Ricotta was the only cheese type analyzed that showed a high frequency of isolation (45.0%). Among meat products, salami and raw ham (25.0% of samples positive) and, to a lesser extent, baloney (5.0%) were found positive for Aeromonas spp. Aeromonas hydrophila was the most common isolate from foods of animal origin, whereas Aeromonas caviae was the dominant species in vegetables. No motile aeromonads were found in ice cream samples. Aeromonas isolates showed a high level of genetic heterogeneity, because 24 PFGE patterns were identified among 27 A. hydrophila strains and 20 PFGE patterns were found in 23 A. caviae isolates. In conclusion, consumers of ready-to-eat foods in Italy are regularly exposed to many genetically distinct strains of A. hydrophila and A. caviae without evident signs of malaise, and therefore, few of these strains, if any, are likely to be pathogenic
The use of opioids for breakthrough pain in acute palliative care unit by using doses proportional to opioid basal regimen.
OBJECTIVES: To determine the efficacy and safety of different opioids used in doses proportional to the basal opioid regimen for the management of breakthrough pain (BP). METHODS: In 66 patients consecutive patients admitted to a pain relief and palliative care unit, the efficacy and safety of different opioids used in doses proportional to the basal opioid regimen for the management of breakthrough pain (BP) were assessed. The choice of the opioid to be administered as rescue medication was based on the characteristics of patients, clinical stability, compliance, preference, and so on. For each episode, nurses were instructed to routinely collect changes in pain intensity and emerging problems when pain became severe (T0), and to re-assess the patient 15 minutes after the opioid given as a rescue medication (T15). RESULTS: Six hundred twenty four episodes of BP were recorded during admission. Intravenous morphine (IV-MO) and oral transmucosal fentanyl (OTFC) were most frequently administered. Of 503 events available, 427 episodes were defined as successfully treated, while 76 episodes required a further administration of opioids. Pain intensity significantly decreased at T15 in all the groups (P<0.001). In 97.2% and 90.7% of cases treated with IV-MO, BP events had a reduction in pain intensity of more than 33% and 50%, respectively. In 99.2% and 97.6% patients receiving OTFC, BP events had a reduction in pain intensity of more than 33% and 50%, respectively. DISCUSSION: This survey suggests that doses of opioids for BP proportional to the basal opioid regimen, are very effective and safe in clinical practice, regardless the opioid and modality used
Transmucosal fentanyl vs intravenous morphine in doses proportional to basal opioid regimen for episodic-breakthrough pain
The use of supplemental doses of opioids is commonly suggested to manage breakthrough pain. A comparative study of intravenous morphine (IV-MO) and oral transmucosal fentanyl citrate (OTFC) given in doses proportional to the basal opioid regimen was performed in 25 cancer patients receiving stable opioid doses. For each episode, when it occurred and 15 and 30 min after the treatment, pain intensity and opioid-related symptoms were recorded. Fifty-three couples of breakthrough events, each treated with IV-MO and OTFC, were recorded. In episodes treated with IV-MO, pain intensity decreased from a mean of 6.9 to 3.3 and to 1.7 at T1 and T2, respectively. In episodes treated with OTFC, pain intensity decreased from a mean of 6.9 to 4.1 and to 2.4 at T1 and T2, respectively. Statistical differences between the two treatments were found at T1 (P=0.013), but not at T2 (P=0.059). Adverse effects were comparable and were not significantly related with the IV-MO and OTFC doses. Intravenous morphine and OTFC in doses proportional to the scheduled daily dose of opioids were both safe and effective, IV-MO having a shorter onset than OTFC. Future comparative studies with appropriate design should compare titration methods and proportional methods of OTFC dosing
Seroprevalence of Toxoplasma gondii in swine slaughtered in Sicily
Several studies showed that the consumption of raw or undercooked meat contaming Toxoplasma gondii tissue cysts from infected animals is one of the most important sources of human toxoplasmosis. Foods of animal origin most frequently contaminated are pork and small ruminants\u27 meat. In order to investigate the seroprevalence of Toxoplasmosis in Sicilian pig farms, 1063 swine sera were collected dunng the slaughtering from locally born and bred ammals and 1312 from imported ones (from France and Spain). The local animals came from 154 farms distributed along Sicily, representing pigs of all ages: the others came from lairages
- …